2009•Journal of Shandong UniversityRequires access

Expressions of cyclooxygenase-2 mRNA and heparanase mRNA in renal cell carcinoma.

Ren JuChao, Cheng Li, Xin-Lan Qi, Zhonghua Xu, Wei Jiao, Lei Yan, Fan YiDong, Zhaoxu Liu, Zheng BaoZhong, Zunlin Zhou, Hainan Liu

Open publisher page 0 citations

Abstract

Objective To detect mRNA expressions of cyclooxygenase-2(COX-2) and heparanase(Hpa) in renal cell carcinoma(RCC),and to investigate their correlation with carcinogenesis,development and prognosis of RCC.Methods Semi-quantitative reversed-transcription polymerase chain reaction(semiquantitative RT-PCR) was used to detect mRNA expressions of COX-2 and Hpa in 56 samples of RCC tissues and 28 samples of the adjacent-tumor renal tissues,and β-actin served as a quantitative standard marker.Different expressions in RCC tissues and adjacent-tumor renal tissues were compared and their relations with clinical pathology parameters and prognosis were analyzed.Results Among 56 cases of RCC tissues,the positive rate of COX-2 mRNA and Hpa mRNA expressions was 73.2% and 67.9%,both were significantly higher than those in the adjacent-tumor renal tissues (χ2=17.719,P0.05;χ2=21.429,P0.05).Low grade(Fuhrman grades 1 and 2) RCC showed a higher COX-2 mRNA expression than high grade ones(Fuhrman grades 3 and 4)(χ2=30.727,P0.05).The relationship between COX-2 mRNA expression and prognosis of RCC patients was not significant(χ2=0.890,P0.05).Expression of Hpa m RNA was related to Fuhrman grade of RCC(χ2=7.718,P0.05),clinical stage(χ2=3.963,P0.05),and lymphatic metastasis(χ2=3.852,P0.05).The relationship between Hpa mRNA expression and prognosis of RCC patients was significant(χ2=12.72,P0.05).There was no relationship between COX-2 mRNA and Hpa mRNA expression(r=-0.244,P0.05).Conclusion COX-2 mRNA expression is an early molecule occurrence of RCC genesis.Hpa mRNA expression can predict the invasion and metastasis of RCC and can be used as a marker for prognosis of RCC.

About this research paper

What this paper is about

Objective To detect mRNA expressions of cyclooxygenase-2(COX-2) and heparanase(Hpa) in renal cell carcinoma(RCC),and to investigate their correlation with carcinogenesis,development and prognosis of RCC.Methods Semi-quantitative reversed-transcription polymerase chain reaction(semiquantitative RT-PCR) was used to detect mRNA expressions of COX-2 and Hpa in 56 samples of RCC tissues and 28 samples of the adjacent-tumor renal tissues,and β-actin served as a quantitative standard marker.Different expressions in RCC tissues and adjacent-tumor renal tissues were compared and their relations with clinical pathology parameters and prognosis were analyzed.Results Among 56 cases of RCC tissues,the positive rate of COX-2 mRNA and Hpa mRNA expressions was 73.2% and 67.9%,both were significantly higher than those in the adjacent-tumor renal tissues (χ2=17.719,P0.05;χ2=21.429,P0.05).Low grade(Fuhrman grades 1 and 2) RCC showed a higher COX-2 mRNA expression than high grade ones(Fuhrman grades 3 and 4)(χ2=30.727,P0.05).The relationship between COX-2 mRNA expression and prognosis of RCC patients was not significant(χ2=0.890,P0.05).Expression of Hpa m RNA was related to Fuhrman grade of RCC(χ2=7.718,P0.05),clinical stage(χ2=3.963,P0.05),and lymphatic metastasis(χ2=3.852,P0.05).The relationship between Hpa mRNA expression and prognosis of RCC patients was significant(χ2=12.72,P0.05).There was no relationship between COX-2 mRNA and Hpa mRNA expression(r=-0.244,P0.05).Conclusion COX-2 mRNA expression is an early molecule occurrence of RCC genesis.Hpa mRNA expression can predict the invasion and metastasis of RCC and can be used as a marker for prognosis of RCC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect mRNA expressions of cyclooxygenase-2(COX-2) and heparanase(Hpa) in renal cell carcinoma(RCC),and to investigate their correlation with carcinogenesis,development and prognosis of RCC.Methods Semi-quantitative reversed-transcription polymerase chain reaction(semiquantitative RT-PCR) was used to detect mRNA expressions of COX-2 and Hpa in 56 samples of RCC tissues and 28 samples of the adjacent-tumor renal tissues,and β-actin served as a quantitative standard marker.Different expressions in RCC tissues and adjacent-tumor renal tissues were compared and their relations with clinical pathology parameters and prognosis were analyzed.Results Among 56 cases of RCC tissues,the positive rate of COX-2 mRNA and Hpa mRNA expressions was 73.2% and 67.9%,both were significantly higher than those in the adjacent-tumor renal tissues (χ2=17.719,P0.05;χ2=21.429,P0.05).Low grade(Fuhrman grades 1 and 2) RCC showed a higher COX-2 mRNA expression than high grade ones(Fuhrman grades 3 and 4)(χ2=30.727,P0.05).The relationship between COX-2 mRNA expression and prognosis of RCC patients was not significant(χ2=0.890,P0.05).Expression of Hpa m RNA was related to Fuhrman grade of RCC(χ2=7.718,P0.05),clinical stage(χ2=3.963,P0.05),and lymphatic metastasis(χ2=3.852,P0.05).The relationship between Hpa mRNA expression and prognosis of RCC patients was significant(χ2=12.72,P0.05).There was no relationship between COX-2 mRNA and Hpa mRNA expression(r=-0.244,P0.05).Conclusion COX-2 mRNA expression is an early molecule occurrence of RCC genesis.Hpa mRNA expression can predict the invasion and metastasis of RCC and can be used as a marker for prognosis of RCC.

Key concepts: Renal cell carcinoma, Heparanase, Messenger RNA, Real-time polymerase chain reaction, Medicine, Carcinogenesis, Metastasis, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Expressions of cyclooxygenase-2 mRNA and heparanase mRNA in renal cell carcinoma. — Research Paper | ScholarLens